author-photo

Corina Candiani Taitt

3

Papers

3

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

A phase 3 open-label, randomized, multicenter study of imprime PGG in combination with cetuximab in patients with KRAS wild type metastatic colorectal cancer.

2015 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Safety of Imprime PGG, a novel innate immune cell modulator, in adults with stage IV non-small cell lung cancer: an integrated analysis of two randomized phase 2 studies.

2015 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)